9:22 AM
Leo Group India
| ||
| Questcor Pharmaceuticals Has Significant Upside Potential Seeking Alpha Questcor Pharmaceuticals, Inc. (QCOR), a biopharmaceutical company, offers drugs for the cure of multiple sclerosis, infantile spasms and nephrotic syndrome indicators. It primarily produces H.P. Acthar Gel, an injectable drug for the treatment of ... See all stories on this topic » | ||
| US FDA approves Linzess for treatment of IBS-C and CIC pharmabiz.com Ironwood Pharmaceuticals, Inc., an entrepreneurial pharmaceutical company dedicated to the art and science of great drugmaking, and New York-based Forest Laboratories, Inc. have received the US Food and Drug Administration (FDA) approval for Linzess ... See all stories on this topic » | ||
| Exec combines work, studies to run pharmaceutical firm in Myanmar Inquirer.net MANILA, Philippines – This pharmaceutical executive expanded the Filipino-owned United Laboratories company in Myanmar while at the same time passing all his school assignments on time. Aristotle Dimitui, Country General Manager of United ... See all stories on this topic » | ||
| 6 Pharmaceutical Stocks to Buy Now Investorplace.com Questcor Pharmaceuticals (NASDAQ:QCOR) is making headway this week, with the company's rating improving to an A ("strong buy") from a B ("buy") last week. Questcor Pharmaceuticals develops and commercializes novel central nervous system-focused ... See all stories on this topic » | ||
| Australian taxpayers are paying 26 times more than New Zealanders for the anti ... Herald Sun The government's own expert pharmaceutical advisory body has signalled in a new review of the statin medicines that we're paying too much for the drug. Atorvastatin came off patent in April and the price in New Zealand has fallen to just $1.90 per ... See all stories on this topic » | ||
| Connecticut Receives $3.5 Million in Drug Settlement Patch.com Thirty-three other states and the District of Columbia also are participating in the agreement, the largest multi-state consumer protection settlement with a pharmaceutical company. It follows an extensive, four-year investigation and stems from ... See all stories on this topic » | ||
| 5 Pharmaceutical Companies With EMA Catalysts During The Next 3-12 Months Seeking Alpha Pharmaceutical companies very often have a run-up leading into drug approval dates. I usually try to buy the stocks three to nine months before the anticipated catalyst date to make profit from the run-up. I screened for companies that have an European ... See all stories on this topic » | ||
| Health Outcome Liaisons Improve Decision Making for Pharmaceutical Industry ... RedOrbit 31, 2012 /PRNewswire/ — As healthcare outcomes data gains more influence with decision makers, Pharmaceutical and Medical Device executives are increasing their attention to the Health Outcomes Liaison (HOL) function. A new Best Practices, LLC study ... See all stories on this topic » | ||
| Investing lessons from skinny monkeys MarketWatch But behind the bad news are some interesting insights about how to invest in pharmaceutical companies. The lesson: stick with larger, diversified companies that don't rely too heavily on any one blockbuster drug and that can survive when some of their ... See all stories on this topic » |
Tip: Use a minus sign (-) in front of terms in your query that you want to exclude. Learn more.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment